His primary areas of investigation include Pathology, Melanoma, Dermatology, Immunology and Nevus. His Pathology study frequently draws connections to other fields, such as Angioma. His Melanoma research is multidisciplinary, incorporating elements of Surgery, Metastasis and Lymph node.
He combines subjects such as Sentinel lymph node and Disease with his study of Metastasis. His Dermatology research focuses on Blue nevus and how it relates to Malignancy. His Cutaneous melanoma research is multidisciplinary, relying on both Cancer, Breslow Thickness, Risk factor and Lymph.
Martin C. Mihm mainly focuses on Pathology, Melanoma, Dermatology, Immunology and Nevus. His Pathology study frequently involves adjacent topics like Metastasis. Martin C. Mihm interconnects Cancer, Internal medicine, Lymph node and Oncology in the investigation of issues within Melanoma.
His Dermatology research includes elements of Melanocytic nevus, Biopsy, Blue nevus and Dysplastic nevus. His Biopsy study frequently links to related topics such as Sentinel lymph node. As part of his studies on Immunology, Martin C. Mihm often connects relevant areas like Cancer research.
Martin C. Mihm spends much of his time researching Pathology, Melanoma, Dermatology, Nevus and Internal medicine. His Pathology study integrates concerns from other disciplines, such as Superficial spreading melanoma and Metastasis. His studies deal with areas such as Immune system, Immunology, Cancer and Sentinel lymph node as well as Melanoma.
His research integrates issues of Spitz nevus and Lymph node in his study of Sentinel lymph node. He has researched Dermatology in several fields, including Melanocytic nevus, Biopsy, Blue nevus and Dysplastic nevus. His Internal medicine study which covers Oncology that intersects with Breslow Thickness and Survival rate.
His primary scientific interests are in Melanoma, Pathology, Dermatology, Immunology and Cancer research. His research in Melanoma is mostly concerned with Cutaneous melanoma. The Pathology study combines topics in areas such as Rats sprague dawley, Metastasis, Port-wine stain, Revascularization and Vascular malformation.
His study in Dermatology is interdisciplinary in nature, drawing from both Biopsy, Nevus, Spitz nevus and Medical diagnosis. His study looks at the relationship between Immunology and fields such as Cancer, as well as how they intersect with chemical problems. His Cancer research study incorporates themes from Carcinogenesis, Ipilimumab and Lymphocyte.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson.
Journal of Clinical Oncology (2009)
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
Wallace H. Clark;Lynn From;Evelina A. Bernardino;Martin C. Mihm.
Cancer Research (1969)
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
F. Stephen Hodi;Martin C. Mihm;Robert J. Soiffer;Frank G. Haluska.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
Stefano Monti;Kerry J. Savage;Jeffery L. Kutok;Friedrich Feuerhake.
GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas
Paula E. North;Milton Waner;Milton Waner;Adam Mizeracki;Adam Mizeracki;Martin C. Mihm;Martin C. Mihm.
Human Pathology (2000)
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
R Soiffer;T Lynch;M Mihm;K Jung.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Cancer classification using the Immunoscore: a worldwide task force
Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell.
Journal of Translational Medicine (2012)
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.
Charles M. Balch;Seng Jaw Soong;Alfred A. Bartolucci;Marshall M. Urist.
Annals of Surgery (1996)
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
F. Stephen Hodi;Marcus Butler;Darryl A. Oble;Michael V. Seiden;Michael V. Seiden.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian;Yufei Xu;Craig Ceol;Craig Ceol;Feizhen Wu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: